Chand, M <br/><br/>
EMVI-positive stage II rectal cancer has similar clinical outcomes as stage III disease following pre-operative chemoradiotherapy.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  Apr 2014 
 - 858-863 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1569-8041 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdu029  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Combined Modality Therapy<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Injections, Intravenous<br/>Male<br/>Middle Aged<br/>Neoadjuvant Therapy<br/>Neoplasm Staging<br/>Preoperative Period<br/>Prognosis<br/>Proportional Hazards Models<br/>Rectal Neoplasms--drug therapy<br/>Treatment Outcome